Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer

Clinical trial NCT00323869 · COMPLETED

Trial details

NCT number: NCT00323869
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non-small Cell Lung Cancer (NSCLC)

Start date: 2006-06-01
Primary completion: 2013-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.